Skip to main content
. 2018 Mar 18;79(2):199–207. doi: 10.15288/jsad.2018.79.199

Figure 2.

Figure 2.

Study flow chart, assessment completion rates, and analysis sample size. MM = medication management; CBI = combined behavioral intervention; NTX = naltrexone; ACAMP = acamprosate; PCQw16 = Process of Change Questionnaire completed in week 16 (end of treatment); PHDD12 = percent heavy drinking days completed in month 12 (12 months following end of treatment); DrInC12 = Drinker Inventory of Consequences completed in month 12 (12 months following end of treatment).